DPG Mitgliedschaft
This block is broken or missing. You may be missing content or you might need to enable the original module.
Keyword: HPAPI
Topstories
11.09.2020
-
The pharmaceutical industry is increasingly focused on the development of specialized drug products with new treatment modalities, including previously undruggable...
Topstories
10.09.2020
-
For biopharma leaders it is more critical than ever to secure the capabilities to contain, handle, develop and manufacture highly potent APIs.
News
04.10.2018
- Lonza and Clovis Oncology have opened a new, dedicated production train for Rubraca (rucaparib), at Lonza’s Visp site in Switzerland. Rubraca is Clovis’ US- and EU-approved drug...
Topstories
27.09.2017
- 2017 marks the 200th anniversary of UK specialty chemical and technology group Johnson Matthey which – back in 1817 – began as assayers, testing the purity of precious metals. In...
Topstories
24.05.2017
- Johnson Matthey, which was founded in London in 1817, is celebrating its 200th anniversary this year. Through the constant application of new ideas and new processes, the company...
Topstories
07.10.2015
- In late June, Johnson Matthey announced that it will divest its Alfa Aesar Research Chemicals business to Thermo Fisher Scientific. Following the divestment the company has...
News
18.10.2012
- Saltigo, the custom manufacturing business of Lanxess' Advanced Intermediates segment, which achieved total sales of €1.5 billion in 2011, has realigned its strategy. The company...
Topstories
25.09.2012
- A Spoonful of Safety - Demand in the pharmaceutical industry has sharply increased for the manufacture of targeted and potent drugs that improve efficacy and reduce side effects...
Ehrenamtliches Engagement
This block is broken or missing. You may be missing content or you might need to enable the original module.
